Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.1.01829
European Journal of Endocrinology, Vol 152, Issue 2, 165-170
Copyright © 2005 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clayton, P E
Right arrow Articles by Tauber, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clayton, P E
Right arrow Articles by Tauber, M
CONSENSUS STATEMENT

Consensus statement on the management of the GH-treated adolescent in the transition to adult care

P E Clayton, R C Cuneo1, A Juul2, J P Monson3, S M Shalet4 and M Tauber5

Endocrine Science Research Group, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK, 1 Metabolic Research Unit, University of Queensland and the Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Australia, 2 Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark, 3 St Bartholomew’s Hospital, London, UK, 4 Christie Hospital, Manchester, UK and 5 Hôpital des Enfants, Toulouse, France

(Correspondence should be addressed to P E Clayton; Email: peter.clayton{at}man.ac.uk)

Abstract

The European Society for Paediatric Endocrinology held a consensus workshop in Manchester, UK in December 2003 to discuss issues relating to the care of GH-treated patients in the transition from paediatric to adult life. Clinicians experienced in the care of paediatric and adult patients on GH treatment, from a wide range of countries, as well as medical representatives from the pharmaceutical manufacturers of GH participated.




This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
A. Giustina, G. Mazziotti, and E. Canalis
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Endocr. Rev., August 1, 2008; 29(5): 535 - 559.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
K. K Y Ho and on behalf of the 2007 GH Deficiency Consensus Work
Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia
Eur. J. Endocrinol., December 1, 2007; 157(6): 695 - 700.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
G. Corneli, C. Di Somma, F. Prodam, J. Bellone, S. Bellone, V. Gasco, R. Baldelli, S. Rovere, H. J. Schneider, L. Gargantini, et al.
Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults
Eur. J. Endocrinol., December 1, 2007; 157(6): 701 - 708.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
C. Hoybye, P. Jonsson, J. P Monson, M. Koltowska-Haggstrom, V. Hana, M. Geffner, and R. Abs
Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency
Eur. J. Endocrinol., November 1, 2007; 157(5): 589 - 596.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Gelwane, C. Garel, D. Chevenne, P. Armoogum, D. Simon, P. Czernichow, and J. Leger
Subnormal Serum Insulin-Like Growth Factor-I Levels in Young Adults with Childhood-Onset Nonacquired Growth Hormone (GH) Deficiency Who Recover Normal GH Secretion May Indicate Less Severe but Persistent Pituitary Failure
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3788 - 3795.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
D. S. Hardin, S. F. Kemp, and D. B. Allen
Twenty Years of Recombinant Human Growth Hormone in Children: Relevance to Pediatric Care Providers
Clinical Pediatrics, May 1, 2007; 46(4): 279 - 286.
[Abstract] [PDF]

Home page
 Eur J EndocrinolHome page
C. L Acerini, R. C Tasker, S. Bellone, G. Bona, C. J Thompson, and M. O Savage
Hypopituitarism in childhood and adolescence following traumatic brain injury: the case for prospective endocrine investigation.
Eur. J. Endocrinol., November 1, 2006; 155(5): 663 - 669.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Maghnie, L. Ambrosini, M. Cappa, G. Pozzobon, L. Ghizzoni, M. G. Ubertini, N. di Iorgi, C. Tinelli, S. Pilia, G. Chiumello, et al.
Adult Height in Patients with Permanent Growth Hormone Deficiency with and without Multiple Pituitary Hormone Deficiencies
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2900 - 2905.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Cianfarani, A. Liguori, S. Boemi, M. Maghnie, L. Iughetti, M. Wasniewska, M. E. Street, S. Zucchini, G. Aimaretti, and D. Germani
Inaccuracy of Insulin-Like Growth Factor (IGF) Binding Protein (IGFBP)-3 Assessment in the Diagnosis of Growth Hormone (GH) Deficiency from Childhood to Young Adulthood: Association to Low GH Dependency of IGF-II and Presence of Circulating IGFBP-3 18-Kilodalton Fragment
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6028 - 6034.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 European Society of Endocrinology.